Article citationsMore>>

H. F. Brulez, C. van Guldener, A. J.Donker , P. M. ter Wee, “The Impact of an Amino Acid-Based Peritoneal Dialysis Fluid on Plasma Total Homocysteine Levels, Lipid Profile and Body Fat Mass,” Nephrology Dialysis Transplantation, Vol. 14, No. 1, 1999, pp. 154-159. doi:10.1093/ndt/14.1.154

has been cited by the following article:

• TITLE: Do We Have a Biocompatible Peritoneal Dialysis Fluid?

  AUTHORS: Shadi Hassan, Batya Kristal, Khalid Khazim, Fadi Hassan, Dunia Hassan, Kamal Hassan

  KEYWORDS: Icodextrin; Amino Acids PDF; Homocyteine; Carbohydrates; Lipids; Inflammation

  JOURNAL NAME: Open Journal of Nephrology, Vol.2 No.3, September 26, 2012

  ABSTRACT: Objective: Cardiovascular disease remains the leading cause of morbidity and mortality in patients on maintenance dialysis. Diabetes mellitus, dyslipidemia, hypertension, inflammation and hyperhomocyteinemia are major cardiovascular risk factors. Aim: to evaluate the effects of Icodextrin and amino acid peritoneal dialysis fluid (AAPDF) on these major cardiovascular risk factors looking for a more biocompatible PDF formula. Methods: 24 adult stable peritoneal dialysis patients were included in the study. 12 patients received 2L Icodextrin and other 12 patients received 2L AAPDF in their dialysis prescription for 8 weeks. Results: Icodextrin decreased fasting plasma glucose (p Conclusions: A biocompatible PDF should provide not only adequate dialysis and ultrafiltration but should also improve nutritional and metabolic status, blood pressure control and reduce inflammation and plasma homocyteine.